ArticleCell death & disease2022

Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma.

Elana Thieme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.